[1]
“CLINICAL AND PATHOGENETIC FEATURES OF PSORIASIS IN PATIENTS WITH METABOLIC SYNDROME AND WAYS OF IMPROVING PERSONALIZED THERAPY”, ReFocus, vol. 4, no. 12, pp. 291–297, Jan. 2026, doi: 10.66073/researchfocus.v4i12.1941.